Mrv1652310201622382D 18 19 0 0 1 0 999 V2000 -0.6078 4.3527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6078 3.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 3.1152 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.0367 3.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7512 3.1152 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.0367 4.3527 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 4.7652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 5.5902 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 2.2902 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.6548 1.8053 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.9097 1.0206 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.7347 1.0206 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.9897 1.8053 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.2197 0.3532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8841 -0.4005 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.4248 0.3532 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.1298 2.0602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9144 2.3151 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 2 0 0 0 0 4 6 1 0 0 0 0 6 7 2 0 0 0 0 1 7 1 0 0 0 0 7 8 1 0 0 0 0 9 3 1 1 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 9 13 1 0 0 0 0 12 14 1 1 0 0 0 14 15 1 0 0 0 0 11 16 1 6 0 0 0 10 17 1 1 0 0 0 17 18 3 0 0 0 0 M END > DB11667 > drugbank > NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1C#N > InChI=1S/C10H12N4O4/c11-3-5-8(16)6(4-15)18-9(5)14-2-1-7(12)13-10(14)17/h1-2,5-6,8-9,15-16H,4H2,(H2,12,13,17)/t5-,6+,8-,9+/m0/s1 > DCYBPMFXJCWXNB-JWIUVKOKSA-N > C10H12N4O4 > 252.23 > 252.085854882 > 7 > 30 > 23.107202933142787 > 1 > 3 > 0 > 0 > (2R,3S,4S,5R)-2-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-4-hydroxy-5-(hydroxymethyl)oxolane-3-carbonitrile > -1.60 > -2.441920297333333 > -1.00 > 0 > 2 > 0 > 14.7023383995177 > 13.120676009435794 > -0.23333696750985877 > 132.17000000000002 > 58.40250000000001 > 2 > 1 > 2.51e+01 g/l > (2R,3S,4S,5R)-2-(4-amino-2-oxopyrimidin-1-yl)-4-hydroxy-5-(hydroxymethyl)oxolane-3-carbonitrile > 0 > DB11667 > investigational > Radgocitabine > 2'-cyano-2'-deoxy-1-(beta-D-arabinofuranosyl)cytosine; CNDAC; Radgocitabine $$$$